ORIENTI, ISABELLA
ORIENTI, ISABELLA
FABIT - DIPARTIMENTO DI FARMACIA E BIOTECNOLOGIE
Docenti di ruolo di Ia fascia
High-throughput in vitro drug screening and in vivo studies identify fenretinide as a brain-penetrant DMG therapeutic
2025 Upton, Dannielle H; Liu, Jie; George, Sandra M; Valvi, Santosh; Ung, Caitlin; Rayner, Benjamin S; Gopalakrishnan, Anjana; Pandher, Ruby; Khan, Aaminah; Venkat, Pooja; Mayoh, Chelsea; Holliday, Holly; Yeung, Nicole; Nguyen, Hieu; Franshaw, Laura; Ehteda, Anahid; Shen, Han; Farruggia, Giovanna; Orienti, Isabella; Reynolds, C Patrick; Tsoli, Maria; Ziegler, David S
A nanoencapsulated oral formulation of fenretinide promotes local and metastatic breast cancer dormancy in HER2/neu transgenic mice
2024 De Angelis, M. L.; Francescangeli, F.; Arico, E.; Verachi, P.; Zucchetti, M.; Matteo, C.; Petricci, E.; Pilozzi, E.; Orienti, I.; Boe, A.; Eramo, A.; Rossi, R.; Corati, T.; Macchia, D.; Pacca, A. M.; Zeuner, A.; Baiocchi, M.
Antiproliferative and Morphological Effects of Fenretinide Lipid Nanosystems in Colon Adenocarcinoma Cells
2024 Anconelli, Lorenzo; Farioli, Francesca; Lodeserto, Pietro; Andreadi, Aikaterini; Borsetti, Francesca; Voltattorni, Manuela; Galassi, Lucrezia; Rossi, Martina; Farruggia, Giovanna; Blasi, Paolo; Orienti, Isabella
Nano-fenretinide demonstrates remarkable activity in acute promyeloid leukemia cells
2024 Farruggia G.; Anconelli L.; Galassi L.; Voltattorni M.; Rossi M.; Lodeserto P.; Blasi P.; Orienti I.
Validated LC-MS/MS Assay for the Quantitative Determination of Fenretinide in Plasma and Tumor and Its Application in a Pharmacokinetic Study in Mice of a Novel Oral Nanoformulation of Fenretinide
2024 Matteo, C.; Orienti, I.; Eramo, A.; Zeuner, A.; Ferrari, M.; Passoni, A.; Bagnati, R.; Ponzo, M.; Bello, E.; Zucchetti, M.; Frapolli, R.
Naxitamab Activity in Neuroblastoma Cells Is Enhanced by Nanofenretinide and Nanospermidine
2023 Lucrezia Galassi; Martina Rossi; Pietro Lodeserto; Monia Lenzi; Francesca Borsetti; Manuela Voltattorni; Giovanna Farruggia; Paolo Blasi; Isabella Orienti
Fenretinide in Cancer and Neurological Disease: A Two-Face Janus Molecule
2022 Potenza RL, Lodeserto P, Orienti I
Nanospermidine in Combination with Nanofenretinide Induces Cell Death in Neuroblastoma Cell Lines
2022 Lodeserto, Pietro; Rossi, Martina; Blasi, Paolo; Farruggia, Giovanna; Orienti, Isabella
Fenretinide Beneficial Effects on Amyotrophic Lateral Sclerosis-associated SOD1 G93A Mutant Protein Toxicity: In Vitro and In Vivo Evidences
2021 Orienti, I; Armida, M; Dobrowolny, G; Pepponi, R; Sollazzini, G; Pezzola, A; Casola, I; Musarò, A; Popoli, P; Potenza, Rl.
RARE-08. POTENTIAL NEW THERAPIES FOR DIFFUSE INTRINSIC PONTINE GLIOMAS IDENTIFIED THROUGH HIGH THROUGHPUT DRUG SCREENING
2021 Dannielle Upton, Santosh Valvi, Jie Liu, Nicole Yeung, Sandra George, Caitlin Ung, Aaminah Khan, Laura Franshaw, Anahid Ehteda, Han Shen, Isabella Orienti, Giovanna Farruggia, Patrick Reynolds, Maria Tsoli, and David Ziegler
DIPG-07. HIGH THROUGHPUT DRUG SCREENING IDENTIFIES POTENTIAL NEW THERAPIES FOR DIFFUSE INTRINSIC PONTINE GLIOMAS (DIPGs)
2020 Dannielle Upton, Santosh Valvi, Jie Liu, Nicole Yeung, Sandra George, Caitlin Ung, Aaminah Khan, Laura Franshaw, Anahid Ehteda, Han Shen, Isabella Orienti, Giovanna Farruggia, Christa Nath, Patrick Reynolds, Maria Tsoli, David Ziegler
Nanomicellar Lenalidomide-Fenretinide Combination Suppresses Tumor Growth in an MYCN Amplified Neuroblastoma Tumor
2020 Orienti I.; Farruggia G.; Nguyen F.; Guan P.; Calonghi N.; Kolla V.; Chorny M.; Brodeur G.M.
Pulmonary delivery of fenretinide: A possible adjuvant treatment in COVID-19
2020 Orienti I.; Gentilomi G.A.; Farruggia G.
A cationic nanomicellar complex of the quaternary amphiphilic amine rc16+ with fenretinide as a new multitasking system for antitumor therapy
2019 Orienti I.; Cripe T.P.; Currier M.A.; Cavallari C.; Teti G.; Falconi M.
A new bioavailable fenretinide formulation with antiproliferative, antimetabolic, and cytotoxic effects on solid tumors
2019 Orienti I.; Francescangeli F.; De Angelis M.L.; Fecchi K.; Bongiorno-Borbone L.; Signore M.; Peschiaroli A.; Boe A.; Bruselles A.; Costantino A.; Eramo A.; Salvati V.; Sette G.; Contavalli P.; Zolla L.; Oki T.; Kitamura T.; Spada M.; Giuliani A.; Baiocchi M.; La Torre F.; Melino G.; Tartaglia M.; De Maria R.; Zeuner A.
A novel nanomicellar combination of fenretinide and lenalidomide shows marked antitumor activity in a neuroblastoma xenograft model
2019 Orienti I.; Nguyen F.; Guan P.; Kolla V.; Calonghi N.; Farruggia G.; Chorny M.; Brodeur G.M.
A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cells
2019 Orienti I.; Salvati V.; Sette G.; Zucchetti M.; Bongiorno-Borbone L.; Peschiaroli A.; Zolla L.; Francescangeli F.; Ferrari M.; Matteo C.; Bello E.; Di Virgilio A.; Falchi M.; De Angelis M.L.; Baiocchi M.; Melino G.; De Maria R.; Zeuner A.; Eramo A.
Calcium/Cobalt Alginate Beads as Functional Scaffolds for Cartilage Tissue Engineering
2016 Focaroli, Stefano; Teti, Gabriella; Salvatore, Viviana; Orienti, Isabella; Falconi, Mirella
Preparation and Evaluation of a Novel Class of Amphiphilic Amines as Antitumor Agents and Nanocarriers for Bioactive Molecules
2016 Orienti, Isabella; Falconi, Mirella; Teti, Gabriella; Currier, Mark A.; Wang, Jiang; Phelps, Mitch; Cripe, Timothy P.
Albumin nanocapsules containing fenretinide: pre-clinical evaluation of cytotoxic activity in experimental models of human non-small cell lung cancer.
2015 Pignatta S;Orienti I;Falconi M;Teti G;Arienti C;Medri L;Zanoni M;Carloni S;Zoli W;Amadori D;Tesei A